文献速递肾小球疾病遗传性与小管间质肾病

Klotho蛋白抑制阿霉素肾病中的肾素-血管紧张素系统

Klotho suppresses the renin-angiotensin system in adriamycin nephropathy.
PubMed 文献 · Nephrol Dial Transplant · 2017-01-01

本研究在大鼠阿霉素肾病模型中探讨补充Klotho蛋白的肾脏保护作用。阿霉素降低血清Klotho浓度及肾脏Klotho与E-钙黏蛋白表达,并升高Wnt、TGF-β、血管紧张素原、β-连环蛋白和血管紧张素II。补充Klotho可抑制β-连环蛋白和血管紧张素II升高,而联合TDZD可逆转上述改善,提示Klotho通过抑制Wnt和TGF-β信号减轻肾脏损伤。

要点

  • 阿霉素肾病大鼠血清Klotho浓度及肾脏Klotho表达降低。
  • 补充Klotho可抑制阿霉素诱导的β-连环蛋白和血管紧张素II升高。
  • Klotho联合TDZD可逆转Klotho对β-连环蛋白和血管紧张素II的改善作用。

核心结论

  • Wnt参与阿霉素肾病的发病机制。
  • 补充Klotho蛋白可抑制Wnt信号,改善肾脏血管紧张素II水平。
  • Klotho蛋白似乎通过抑制TGF-β和Wnt信号来抑制上皮-间质转化。

研究设计与样本

  • 大鼠注射阿霉素(5 mg/kg)后分为三组:溶媒对照组、Klotho蛋白治疗组、Klotho联合TDZD治疗组。
  • 未注射阿霉素的大鼠作为对照。

主要发现

  • 阿霉素降低血清Klotho浓度及肾脏Klotho和E-钙黏蛋白表达。
  • 阿霉素增加肾脏Wnt、TGF-β和血管紧张素原表达,以及β-连环蛋白和血管紧张素II的肾脏丰度。
  • 补充Klotho抑制阿霉素诱导的β-连环蛋白和血管紧张素II升高,同时Wnt表达持续存在。
  • Klotho联合TDZD逆转Klotho对β-连环蛋白和血管紧张素II肾脏丰度以及TGF-β和血管紧张素原表达的改善,但不影响E-钙黏蛋白。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUNDS: Klotho protein interacts with the transforming growth factor β (TGF-β) receptor and Wnt, which contribute to the progression of renal disease, inhibiting their signals. Renal and circulating klotho levels are diminished in chronic kidney disease. METHODS: Experiments were performed to assess whether supplementation of klotho protein could have protective effects on the kidney. Rats were injected with adriamycin (5 mg/kg) and divided into three groups: those treated with vehicle, those treated with klotho protein and those treated with klotho plus 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (TDZD). Rats without adriamycin treatment were used as a control. RESULTS: Adriamycin reduced the serum klotho concentration and renal expression of klotho and E-cadherin. Adriamycin also increased the renal expression of Wnt, TGF-β, and angiotensinogen, as well as the renal abundance of β-catenin and angiotensin II. Klotho supplementation suppressed adriamycin-induced elevations of β-catenin and angiotensin II with sustained Wnt expression. Combined treatment with klotho and TDZD reversed the klotho-induced improvements in the renal abundance of β-catenin and angiotensin II as well as the expression of TGF-β and angiotensinogen without affecting E-cadherin. CONCLUSIONS: Our data indicate that Wnt is involved in the pathogenesis of adriamycin nephropathy. Furthermore, klotho supplementation inhibited Wnt signaling, ameliorating renal angiotensin II. Finally, klotho protein appears to suppress epithelial-mesenchymal transition by inhibiting TGF-β and Wnt signaling.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Takenaka T, Inoue T, Miyazaki T, et al. Klotho suppresses the renin-angiotensin system in adriamycin nephropathy. Nephrol Dial Transplant. 2017. PMID: 27798196. doi:10.1093/ndt/gfw340

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。